INTRODUCTION: Diabetic peripheral neuropathy (DPN) is the result of nerve damage in the toes, feet, or hands, causing loss of feeling or pain for up to 50% of patients. The purpose of this qualitative study was to assess the burden and impact of DPN pain (DPNP) symptoms on patient's functioning and well-being. METHODS: Four focus groups and 47 telephone interviews were conducted to understand the experience and impacts of DPNP from the patient's perspective. All participants were over the age of 18 years, read/spoke English, had a documented diagnosis of DPNP with symptoms for 6 months and a minimum 12-month history of diabetes mellitus, and had a daily pain rating of at least 4 on an 11-point numerical rating scale. Interview transcripts were analyzed thematically based on modified grounded theory principles. RESULTS: There were 70 respondents--48 (68.6%) males and 22 (31.4%) females. The mean age was 54.0 years (range 26-70), and nearly all respondents had type 2 diabetes (87%). Analysis identified four major areas of impact; DPNP patients reported difficulties with: (1) physical function, i.e. walking, exercise, energy, standing, balance, bending, and mobility; (2) daily life, i.e. productivity, recreational activities, work, enjoyment, focus, and chores; (3) social/psychological, i.e. anxiety, friends/family, irritability, depression, and fear; and (4) sleep, i.e. sleep, falling asleep, waking in the night, returning to sleep, and not feeling rested upon awakening. CONCLUSION: DPNP is a significant complication of diabetes with multiple impacts for patient functioning and well-being, which increase the burden of disease.
INTRODUCTION:Diabetic peripheral neuropathy (DPN) is the result of nerve damage in the toes, feet, or hands, causing loss of feeling or pain for up to 50% of patients. The purpose of this qualitative study was to assess the burden and impact of DPN pain (DPNP) symptoms on patient's functioning and well-being. METHODS: Four focus groups and 47 telephone interviews were conducted to understand the experience and impacts of DPNP from the patient's perspective. All participants were over the age of 18 years, read/spoke English, had a documented diagnosis of DPNP with symptoms for 6 months and a minimum 12-month history of diabetes mellitus, and had a daily pain rating of at least 4 on an 11-point numerical rating scale. Interview transcripts were analyzed thematically based on modified grounded theory principles. RESULTS: There were 70 respondents--48 (68.6%) males and 22 (31.4%) females. The mean age was 54.0 years (range 26-70), and nearly all respondents had type 2 diabetes (87%). Analysis identified four major areas of impact; DPNP patients reported difficulties with: (1) physical function, i.e. walking, exercise, energy, standing, balance, bending, and mobility; (2) daily life, i.e. productivity, recreational activities, work, enjoyment, focus, and chores; (3) social/psychological, i.e. anxiety, friends/family, irritability, depression, and fear; and (4) sleep, i.e. sleep, falling asleep, waking in the night, returning to sleep, and not feeling rested upon awakening. CONCLUSION: DPNP is a significant complication of diabetes with multiple impacts for patient functioning and well-being, which increase the burden of disease.
Authors: J Todd Coffey; Michael Brandle; Honghong Zhou; Deanna Marriott; Ray Burke; Bahman P Tabaei; Michael M Engelgau; Robert M Kaplan; William H Herman Journal: Diabetes Care Date: 2002-12 Impact factor: 19.112
Authors: Maija Haanpää; Nadine Attal; Miroslav Backonja; Ralf Baron; Michael Bennett; Didier Bouhassira; Giorgio Cruccu; Per Hansson; Jennifer A Haythornthwaite; Gian Domenico Iannetti; Troels S Jensen; Timo Kauppila; Turo J Nurmikko; Andew S C Rice; Michael Rowbotham; Jordi Serra; Claudia Sommer; Blair H Smith; Rolf-Detlef Treede Journal: Pain Date: 2010-09-19 Impact factor: 6.961
Authors: K Van Acker; D Bouhassira; D De Bacquer; S Weiss; K Matthys; H Raemen; C Mathieu; I M Colin Journal: Diabetes Metab Date: 2009-03-17 Impact factor: 6.041
Authors: Ryan T Crews; Kristin L Schneider; Sai V Yalla; Neil D Reeves; Loretta Vileikyte Journal: Diabetes Metab Res Rev Date: 2016-06-10 Impact factor: 4.876
Authors: Matthew Alsaloum; Mark Estacion; Rowida Almomani; Monique M Gerrits; Gidon J Bönhof; Dan Ziegler; Rayaz Malik; Maryam Ferdousi; Giuseppe Lauria; Ingemar Sj Merkies; Catharina G Faber; Sulayman Dib-Hajj; Stephen G Waxman Journal: Mol Pain Date: 2019 Jan-Dec Impact factor: 3.395
Authors: Kushang V Patel; Robert Allen; Laurie Burke; John T Farrar; Jennifer S Gewandter; Ian Gilron; Nathaniel P Katz; John D Markman; Scott F Marshall; Malca Resnick; Andrew S C Rice; Michael C Rowbotham; Shannon M Smith; Geertrui F Vanhove; Ajay D Wasan; Shuyu Zhang; Robert H Dworkin; Dennis C Turk Journal: Pain Date: 2018-11 Impact factor: 7.926
Authors: Gisele Zapata-Sudo; Isabelle Karine da Costa Nunes; Josenildo Segundo Chaves Araujo; Jaqueline Soares da Silva; Margarete Manhães Trachez; Tiago Fernandes da Silva; Filipe P da Costa; Roberto Takashi Sudo; Eliezer J Barreiro; Lídia Moreira Lima Journal: Drug Des Devel Ther Date: 2016-09-09 Impact factor: 4.162
Authors: Raghuveer Chandrashekhar; Hongwu Wang; Carol Dionne; Shirley James; Jenni Burzycki Journal: Int J Environ Res Public Health Date: 2021-03-02 Impact factor: 3.390